On the basis of the on-treatment CD4+ T cell densities at the tumor core and margin, we differentiated T cell–enriched (n = 9), T cell–excluded (n = 11), and T cell–deserted tumors (n = 15) (Fig. 6, C and D). The gene discussed is CD4; the disease is neoplasm.